Senate Simple Resolution 784
116th Congress(2019-2020)
A resolution supporting the goals and ideals of American Diabetes Month.
Active
Passed Senate on Dec 2, 2020
Origin Chamber
Senate
Type
Simple Resolution
Simple Resolution
A form of legislative measure introduced and potentially acted upon by only one congressional chamber and used for the regulation of business only within the chamber of origin. Depending on the chamber of origin, they begin with a designation of either H.Res. or S.Res. Joint resolutions and concurrent resolutions are other types of resolutions.
Bill Number
784
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
checkPassed on December 2, 2020
Status
Passed
Type
Unanimous Consent
Unanimous Consent
A senator may request unanimous consent on the floor to set aside a specified rule of procedure so as to expedite proceedings. If no Senator objects, the Senate permits the action, but if any one senator objects, the request is rejected. Unanimous consent requests with only immediate effects are routinely granted, but ones affecting the floor schedule, the conditions of considering a bill or other business, or the rights of other senators, are normally not offered, or a floor leader will object to it, until all senators concerned have had an opportunity to inform the leaders that they find it acceptable.
Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.(consideration: CR S7189; text: CR S7181)
Summary
This resolution expresses support for (1) the goals and ideals of American Diabetes Month, including encouraging individuals to fight diabetes through public awareness about prevention and treatment options and enhancing education about the disease; and (2) decreasing the prevalence of type 1, type 2, and gestational diabetes in the United States through increased research, treatment, and prevention.
December 2, 2020
12/02/2020
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S7189; text: CR S7181)
12/02/2020
Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.(consideration: CR S7189; text: CR S7181)
12/02/2020
Introduced in Senate
Public Record
Record Updated
Dec 29, 2021 9:58:43 PM